Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors

Name
Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors
Accession Number
DBCAT001704
Description

Not Available

Drugs
DrugDrug Description
GW 468816Investigated for use/treatment in tobacco dependence.
LanicemineLanicemine has been used in trials studying the treatment and basic science of Depression, Major Depressive Disorder, and Treatment Resistant Major Depressive Disorder.
CERC-301Mk 0657 has been used in trials studying the treatment of Major Depressive Disorder.
GW-468816GW-468816 is under investigation in clinical trial NCT00218465 (Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking).
Drugs & Drug Targets
DrugTargetType
GW 468816Glycine receptor subunit alpha-1target